Jupiter Life Line Hospitals Limited has reported a strong financial performance for the third quarter of FY25, with a 29.8% year-on-year (YoY) increase in net profit to ₹42.2 crore from ₹32.5 crore in Q3 FY24. The company’s revenue from operations grew 17.8% YoY to ₹232 crore, up from ₹197 crore in the corresponding quarter last year.
Key Financial Highlights (Q3 FY25 vs. Q3 FY24)
- Revenue from operations: ₹232 crore (+17.8% YoY)
- Net profit: ₹42.2 crore (+29.8% YoY)
- EBITDA: ₹60.3 crore (+20.4% YoY)
- EBITDA margin: 26.0% (vs. 25.2% in Q3 FY24)
- Earnings per share (EPS): ₹6.82 (vs. ₹5.27 in Q3 FY24)
Strategic Updates & Expansion
- Regulatory Approvals for New Pune Hospital:
- The company has received regulatory approvals to construct a new multi-specialty hospital in Bibvewadi, Pune.
- Construction is set to commence in March 2025, further expanding Jupiter’s healthcare network.
- Higher Patient Volumes & Improved Operational Efficiency:
- The hospital chain witnessed higher patient footfalls, driving revenue growth.
- Increased efficiency and cost management contributed to the expansion in EBITDA margins.
Dr. Ankit A. Thakker, Whole-Time Director & CEO, Jupiter Life Line Hospitals, stated:
“We are pleased with our Q3 FY25 performance, which reflects our continued commitment to providing top-quality healthcare services while expanding our presence. The approval for our new Pune hospital is a key milestone, reinforcing our strategic growth plans. We remain focused on delivering operational excellence and enhancing patient care.”
Jupiter Life Line Hospitals continues to focus on expanding its hospital network and improving service offerings to strengthen its presence in India’s growing healthcare sector. With rising demand for specialized medical services, the company expects continued revenue and profitability growth in the upcoming quarters.
